Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Johannes JW"'
Autor:
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert BM Landewé, Johannes JW Bijlsma, Andreas Kerschbaumer, René Westhovens, Tom WJ Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Publikováno v:
Annals of the Rheumatic Diseases. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases
ObjectiveTo investigate the success rate of glucocorticoid (GC) discontinuation during follow-up in observational cohorts and clinical trials using temporary GC as part of initial therapy (‘bridging’) in newly diagnosed patients with rheumatoid a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00e6c2e6cefa37e02e5dbea03c10bd0
https://hdl.handle.net/1887/3329999
https://hdl.handle.net/1887/3329999
Publikováno v:
Poster Presentations.
A research report submitted in fulfilment of the requirements for the degree Master of Science to the Faculty of Health Sciences, School of Therapeutic Sciences, University of the Witwatersrand, Johannesburg, 2021
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f0cfeb0e061813eb68fb571fb816d4e
https://doi.org/10.1136/bjsports-2021-ioc.401
https://doi.org/10.1136/bjsports-2021-ioc.401
Autor:
Ammerlaan, Judy JW, Scholtus, Lieske W, Drossaert, Constance HC, van Os-Medendorp, Harmieke, Prakken, Berent, Kruize, Aike A, Bijlsma, Johannes JW
Publikováno v:
JMIR Research Protocols, Vol 4, Iss 3, p e102 (2015)
BackgroundTo improve knowledge and to encourage active involvement of young adults with juvenile idiopathic arthritis (JIA), an informative website with written and video information and an online portal with access to the personal medical record, se
Externí odkaz:
https://doaj.org/article/06e4c67c166d4bc983265e17aa6b9bae
Autor:
van Ouwerkerk, Lotte, Palmowski, Andriko, Nevins, Isabell S., Buttgereit, Frank, Verschueren, Patrick, Smolen, Josef S., Landewé, Robert B. M., Bijlsma, Johannes J. W., Kerschbaumer, Andreas, Westhovens, René, Huizinga, Tom W. J., Allaart, Cornelia F., Bergstra, Sytske Anne, Landewé, Robert Bm, Bijlsma, Johannes Jw, Huizinga, Tom Wj
Publikováno v:
Annals of the Rheumatic Diseases; Jul2022, Vol. 81 Issue 7, p937-943, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biology of the Neonate; 2005, Vol. 88 Issue 4, p278-290, 13p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Staniszewska AD; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Pilger D; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Gill SJ; Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Jamal K; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Bohin N; Oncology Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Guzzetti S; DMPK, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Gordon J; Oncology R&D, AstraZeneca, Boston, Massachusetts., Hamm G; Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Mundin G; DMPK, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Illuzzi G; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Pike A; DMPK, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., McWilliams L; Discovery Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Maglennon G; Pathology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Rose J; Animal Sciences and Technologies, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Hawthorne G; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom., Cortes Gonzalez M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Halldin C; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Johnström P; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; PET Science Centre at Karolinska Institutet, Precision Medicine and Biosamples, Oncology R&D, Stockholm, Sweden., Schou M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.; PET Science Centre at Karolinska Institutet, Precision Medicine and Biosamples, Oncology R&D, Stockholm, Sweden., Critchlow SE; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Fawell S; Oncology R&D, AstraZeneca, Boston, Massachusetts., Johannes JW; Chemistry, Oncology R&D, AstraZeneca, Boston, Massachusetts., Leo E; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Davies BR; Projects Group, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Cosulich S; Projects Group, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Sarkaria JN; Mayo Clinic, Rochester, Minnesota., O'Connor MJ; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Hamerlik P; Bioscience, Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Apr 01; Vol. 30 (7), pp. 1338-1351.